Eris Lifesciences Q4 PAT up 21% YoY on strong show by superspecialty biz ...Middle East

Business Standard - Economy
Eris Lifesciences Q4 PAT up 21% YoY on strong show by superspecialty biz
Consolidated total income up 13%; robust anti-diabetic sales, new product pipeline, expanded coverage of cardiologists support better numbers

Hence then, the article about eris lifesciences q4 pat up 21 yoy on strong show by superspecialty biz was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Eris Lifesciences Q4 PAT up 21% YoY on strong show by superspecialty biz )

Apple Storegoogle play

Last updated :

Also on site :